CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies.
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T细胞疗法改变了血液系统恶性肿瘤的治疗模式。然而,超过半数患者无法实现持续肿瘤控制,部分原因是CAR-T 细胞清除肿瘤细胞的效力不足。T细胞是抗肿瘤免疫应答的关键组成,T细胞内在的多种特征会显著影响CAR-T 疗法结局。本文综述影响CAR-T 疗效的T细胞特征研究进展,包括T细胞耗竭、记忆亚群、衰老、调节性T细胞、CD4+与CD8+ T细胞比值、代谢及T细胞受体库。全面理解成功CAR-T 治疗背后的生物学过程,将有助于进一步优化这些新型治疗方式,提高患者治疗效力和安全性。
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment paradigms for hematological malignancies.
However, more than half of these patients cannot achieve sustainable tumor control, partially due to the inadequate potency of CAR-T cells in eradicating tumor cells. T cells are crucial components of the anti-tumor immune response, and multiple intrinsic T-cell features significantly influence the outcomes of CAR-T cell therapy.
Herein, we review progressing research on T-cell characteristics that impact the effectiveness of CAR-T cells, including T-cell exhaustion, memory subsets, senescence, regulatory T-cells, the CD4 + to CD8 + T-cell ratio, metabolism, and the T-cell receptor repertoire. With comprehensive insight into the biological processes underlying successful CAR-T cell therapy, we will further refine the applications of these novel therapeutic modalities, and enhance their efficacy and safety for patients.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。